EP1-antagonist-1 is primarily used in research settings to study the role of the EP1 receptor in various physiological and pathological processes. It is particularly valuable in investigating inflammatory conditions, as the EP1 receptor is known to be involved in mediating inflammatory responses. Researchers utilize this compound to explore its potential therapeutic effects in diseases such as chronic pain, where EP1 receptor signaling plays a significant role. Additionally, it is employed in studies related to cardiovascular health, as EP1 receptors are implicated in regulating blood pressure and vascular function. By blocking EP1 receptor activity, this compound helps elucidate the receptor's contribution to these processes and aids in the development of targeted treatments for related disorders.